T1	PROC 46 96	Estudio para investigar la eficacia y la seguridad
T2	PROC 101 112	tratamiento
#1	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	PROC 146 153	placebo
#2	AnnotatorNotes T3	C0032042; Placebos; Therapeutic or Preventive Procedure
T4	DISO 171 175	asma
#3	AnnotatorNotes T4	C0004096; Asthma; Disease or Syndrome
T5	PROC 222 242	tratamiento estandar
#4	AnnotatorNotes T5	C2936643; Standard of Care; Health Care Activity
T6	CHEM 268 284	corticosteroides
#5	AnnotatorNotes T6	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T7	CHEM 299 313	agonistas beta
#6	AnnotatorNotes T7	C0001644; Adrenergic beta-Agonists; Pharmacologic Substance
T8	CHEM 342 358	corticosteroides
#7	AnnotatorNotes T8	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T9	PROC 389 461	Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo
T10	PROC 467 504	investigar la eficacia y la seguridad
T11	PROC 509 520	tratamiento
#8	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 580 584	asma
#9	AnnotatorNotes T12	C0004096; Asthma; Disease or Syndrome
T13	CHEM 652 654	CI
#10	AnnotatorNotes T13	C2065041; inhaled steroids; Pharmacologic Substance
T14	CHEM 674 676	CO
#11	AnnotatorNotes T14	C3653473; Corticosteroids for local oral treatment; Organic Chemical · Pharmacologic Substance
T15	DISO 700 704	Asma
#12	AnnotatorNotes T15	C0004096; Asthma; Disease or Syndrome
T16	PROC 738 749	Diagnóstico
#13	AnnotatorNotes T16	C0011900; Diagnosis; Diagnostic Procedure
T17	DISO 753 766	asma alérgica
#14	AnnotatorNotes T17	C0155877; Allergic asthma; Disease or Syndrome
T18	CHEM 788 798	medicación
#15	AnnotatorNotes T18	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T19	DISO 836 860	exacerbaciones asmáticas
T20	PROC 894 935	Volumen Expiratorio Forzado en un segundo
T21	CHEM 1076 1091	broncodilatador
#16	AnnotatorNotes T21	C0006280; Bronchodilator Agents; Pharmacologic Substance
T22	CHEM 1128 1147	productos de tabaco
#17	AnnotatorNotes T22	C0040329; Tobacco; Hazardous or Poisonous Substance · Organic Chemical
T23	DISO 1180 1189	fumadores
#18	AnnotatorNotes T23	C0337664; Smoker; Finding
T24	DISO 1235 1249	ataque de asma
T25	DISO 1250 1287	exacerbación o empeoramiento del asma
T26	DISO 1290 1312	infección respiratoria
#19	AnnotatorNotes T26	C0035243; Respiratory Tract Infections; Disease or Syndrome
T27	CHEM 120 126	QGE031
#20	AnnotatorNotes T27	C5226733; QGE-031; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T28	CHEM 551 557	QGE031
#21	AnnotatorNotes T28	C5226733; QGE-031; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T29	PROC 1055 1069	administracion
#22	AnnotatorNotes T29	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T30	CHEM 659 663	LABA
#23	AnnotatorNotes T30	[long-acting beta agonists]
T31	PROC 937 941	FEV1
#24	AnnotatorNotes T31	C0849974; Pulmonary Function Test/Forced Expiratory Volume 1; Diagnostic Procedure
T32	Date 13 17	2014
T33	LIVB 157 166	pacientes
#25	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T35	Dose 244 264	dosis altas o medias
T36	Route 285 294	inhalados
#26	AnnotatorNotes T36	C0205535; Inhalation Route of Drug Administration; Functional Concept
T37	Duration 314 331	de larga duración
T38	Neg_cue 338 341	sin
T39	Route 359 365	orales
#27	AnnotatorNotes T39	C1527415; Oral Route of Drug administration; Functional Concept
T40	Duration 524 534	52 semanas
T41	Route 558 562	s.c.
#28	AnnotatorNotes T41	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
T42	LIVB 566 575	pacientes
#29	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T44	Dose 628 648	dosis altas o medias
T45	Neg_cue 670 673	sin
T47	Date 799 805	actual
T48	Duration 869 892	los 12 meses anteriores
T50	Duration 925 935	un segundo
T53	LIVB 1021 1029	paciente
#30	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Duration 1156 1178	los 6 meses anteriores
T55	Frequency 1190 1201	ocasionales
T56	Date 1226 1234	Reciente
T59	ANAT 1300 1312	respiratoria
#31	AnnotatorNotes T59	C0035237; Respiratory System; Body System | C1269561; Entire respiratory system; Body System
A1	Assertion T8 Negated
A2	Assertion T14 Negated
A3	Status T19 History_of
A4	Status T24 History_of
A5	Status T25 History_of
A6	Status T26 History_of
#32	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#33	AnnotatorNotes T10	C0511730; Identify product efficacy and safety issues; Health Care Activity
#34	AnnotatorNotes T9	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#35	AnnotatorNotes T20	C0849974; Pulmonary Function Test/Forced Expiratory Volume 1; Diagnostic Procedure
#36	AnnotatorNotes T24	C0038218; Status Asthmaticus; Disease or Syndrome | C0347950; Asthma attack; Disease or Syndrome
#37	AnnotatorNotes T25	C0349790; Exacerbation of asthma; Finding
#38	AnnotatorNotes T19	C0349790; Exacerbation of asthma; Finding
#39	AnnotatorNotes T56	C0332185; Recent; Temporal Concept
#40	AnnotatorNotes T47	C0521116; Current (present time); Temporal Concept 
T34	Neg_cue 180 182	no
T43	Quantifier_or_Qualifier 189 214	controlados adecuadamente
A7	Assertion T43 Negated
T46	Quantifier_or_Qualifier 770 780	controlada
A8	Assertion T46 Negated
T49	Neg_cue 767 769	no
T51	Neg_cue 589 591	no
T52	Quantifier_or_Qualifier 598 623	controlados adecuadamente
A9	Assertion T52 Negated
T57	Quantifier_or_Qualifier 705 711	Severa
#41	AnnotatorNotes T57	C1547227; Severe - Severity of Illness Code; Intellectual Product
R1	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T57	
R2	Negation Arg1:T49 Arg2:T46	
R3	Overlap Arg1:T18 Arg2:T47	
R4	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T46	
T58	Quantifier_or_Qualifier 823 835	al menos dos
R5	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T58	
R6	Has_Duration_or_Interval Arg1:T19 Arg2:T48	
T60	Result_or_Value 943 1016	superior o igual a 40% e inferior o igual al 80% del valor normal teórico
R7	Has_Result_or_Value Arg1:T31 Arg2:T60	
R8	Has_Duration_or_Interval Arg1:T20 Arg2:T50	
R9	Has_Result_or_Value Arg1:T20 Arg2:T60	
R10	Experiences Arg1:T53 Arg2:T20	
R11	Experiences Arg1:T53 Arg2:T31	
R12	Has_Duration_or_Interval Arg1:T31 Arg2:T50	
R13	Used_for Arg1:T21 Arg2:T29	
R14	Experiences Arg1:T53 Arg2:T29	
R15	Has_Duration_or_Interval Arg1:T22 Arg2:T54	
R16	Has_Frequency Arg1:T23 Arg2:T55	
T61	Observation 1202 1222	podrán ser incluidos
#42	AnnotatorNotes T61	C1302261; Patient eligible for clinical trial; Finding (?)
T62	Observation 1032 1046	reversibilidad
#43	AnnotatorNotes T62	C0421207; Airways obstruction reversible; Finding (?) | C5539668; Reversible airflow obstruction; Finding (?)
R18	After Arg1:T62 Arg2:T29	
R19	Experiences Arg1:T53 Arg2:T62	
R20	Used_for Arg1:T27 Arg2:T2	
R21	Experiences Arg1:T33 Arg2:T2	
R22	Experiences Arg1:T33 Arg2:T3	
R23	Experiences Arg1:T33 Arg2:T4	
R24	Negation Arg1:T34 Arg2:T43	
R25	Experiences Arg1:T33 Arg2:T5	
R26	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T43	
R27	Used_for Arg1:T6 Arg2:T5	
R28	Has_Dose_or_Strength Arg1:T6 Arg2:T35	
R29	Has_Route_or_Mode Arg1:T6 Arg2:T36	
R30	Combined_with Arg1:T6 Arg2:T7	
R31	Has_Duration_or_Interval Arg1:T7 Arg2:T37	
R32	Negation Arg1:T38 Arg2:T8	
R33	Has_Route_or_Mode Arg1:T8 Arg2:T39	
R34	Combined_with Arg1:T7 Arg2:T8	
R35	Before Arg1:T5 Arg2:T2	
R36	Before Arg1:T5 Arg2:T3	
R37	Has_Duration_or_Interval Arg1:T28 Arg2:T40	
R38	Used_for Arg1:T28 Arg2:T11	
R39	Has_Route_or_Mode Arg1:T28 Arg2:T41	
R40	Experiences Arg1:T42 Arg2:T11	
R41	Experiences Arg1:T42 Arg2:T12	
R42	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T52	
R43	Negation Arg1:T51 Arg2:T52	
R44	Combined_with Arg1:T13 Arg2:T30	
R45	Combined_with Arg1:T30 Arg2:T14	
R46	Negation Arg1:T45 Arg2:T14	
R47	Has_Dose_or_Strength Arg1:T13 Arg2:T44	
R48	Experiences Arg1:T42 Arg2:T13	
R49	Before Arg1:T13 Arg2:T11	
R50	Before Arg1:T30 Arg2:T11	
R51	Before Arg1:T14 Arg2:T11	
R52	Overlap Arg1:T24 Arg2:T56	
R53	Overlap Arg1:T25 Arg2:T56	
R54	Overlap Arg1:T26 Arg2:T56	
R55	Location_of Arg1:T59 Arg2:T26	
R56	Location_of Arg1:T59 Arg2:T25	
R57	Location_of Arg1:T59 Arg2:T24	
A10	Experiencer T33 Patient
A11	Experiencer T42 Patient
A12	Experiencer T53 Patient
A13	Status T61 Future
